Dr Claire Meaney

Dr Claire Meaney

Junior Council Member

Dr. Claire Meaney is a member of the Research, Development and Innovation team at Limerick Institute of Technology and Principal Investigator within the Shannon Applied Biotechnology Centre. She received her B. Eng in Biomedical Engineering from the University of Limerick and was awarded an Irish Research Council scholarship to conduct her doctoral studies under the supervision of Prof. Tim McGloughlin within the Centre of Applied Biomedical Engineering Research in the University of Limerick’s School of Engineering. Her thesis examined the flow induced stress response of arterial cells with naturally derived vascular graft materials.

After successfully completing her Ph.D at the University of Limerick, Claire was awarded a position on the USA’s National Cancer Institute, Cancer Prevention Fellowship Program. This postdoctoral program was co-funded by the Health Research Board and the National Institutes of Health, USA. As part of Claire’s post-doctoral work, she was funded by the Irish Health Research Board to complete a Masters of Public Health at University College Dublin and her dissertation focused on breast cancer survival characteristics in relation to trastuzumab treatment over a ten year period.

Upon completing her M.P.H., Dr. Meaney and spent three and a half years at the US National Cancer Institute in Bethesda, Maryland, conducting research in biomarker development under the mentorship of Dr. Brid Ryan, and 3D models of tumour microenvironments at the Laboratory of Human Carcinogenesis and Division of Cancer Prevention. While completing her post-doctoral work, Dr. Meaney was competitively selected as a recipient of the 2016/2017 National Cancer Institute, Sallie Rosen Kaplan Leadership Award for Women in Science and served as a Technology Transfer Ambassador for the National Cancer Institute’s collaborative technology transfer programme with Johns Hopkins University and local biotech stakeholders. During her time at the NIH, Dr. Meaney managed multiple research projects, teaching activities, leadership and grant writing training programmes, and worked as part of a team in the development and management of extramural grant mechanisms within the National Institutes of Health Small Business Innovation Research (SBIR) Program.

Upon her return to Ireland, Dr Meaney was awarded a reintegration award to from the Irish Cancer Society and Health Research Board to fund her lung cancer research program in Ireland and began working as an independent principal investigator. The focus of Dr. Meaney’s current research is the computational evaluation of morphologic tumour tissue features as diagnostic and prognostic predictors of lung cancer using digital pathology platforms. Dr. Meaney joined the IACR Junior Council in 2019.

3D mammosphere culture of breast epithelial cell line MCF10A.

Courtesy of Dr. Emer Bourke, NUI Galway

Phospho-Akt expression and localisation

Mediated by VEGF in A549 lung cancer cells. Visualised by high content image analysis.

Courtesy of Dr Martin Barr, Clinical Scientist & Adjunct Assistant Professor, St James’s Hospital & Trinity College Dublin

Metaphase chromosome spread of Jurkat T-lymphoma cells

Courtesy of Rebecca Gorry, PhD Student, Mc Gee Lab, UCD School of Biomolecular & Biomedical Science, Conway Institute, UCD

Apoptosis assessment of SKMES-1 lung cancer cells

Using a multiparameter apoptosis staining kit, showing cell nuclei (blue), actin (green) and mitochondrial activity (orange).

Courtesy of Dr Martin Barr, Clinical Scientist & Adjunct Assistant Professor, St James’s Hospital & Trinity College Dublin

HeLa Cells

Courtesy of Rebecca Gorry, PhD Student, Mc Gee Lab, UCD School of Biomolecular & Biomedical Science, Conway Institute, UCD

IACR & EACR Joint Conference 2020

26 — 28 February 2020 at Galway Bay Hotel, Galway

Mitotic Chronic Myelogenous Leukaemia K562 Cells

Courtesy of Rebecca Gorry, PhD Student, Mc Gee Lab, UCD School of Biomolecular & Biomedical Science, Conway Institute, UCD

Cell to Cell Tweeting

Via nanoparticles (red) in Triple Negative Breast Cancer (TNBC)

Courtesy of Sinéad Lindsay, UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin (UCD) Ireland.

Confocal Microscopy Analysis

Of phospho-Akt expression in H460 lung cancer cells in response to hypoxia (0.5% O2).

Courtesy of Dr Martin Barr, Clinical Scientist & Adjunct Assistant Professor, St James’s Hospital & Trinity College Dublin

Donate to Cancer Research

All donations to the IACR go directly towards supporting early-stage oncology scientific researchers in their work.

IACR 2023 Carer’s Bursary €300

Apply for funding towards the additional costs of care while attending conference. Five Bursaries Available. 

Registration/ Membership for IACR 2023

Registration for the 59th Annual Conference in the Radisson Blu hotel, Athlone is Now Open.

EACR Membership is Included

The IACR is an affiliated national society and its members benefit from full membership of the EACR.

Late Breaking Abstracts in Now OPEN!

Biomedical Session Abstracts

Deadline: Midnight, Friday, 20th January 2023

Please note:
- Patrick Johnston Lay submission category is now closed
- Late Breaking Abstracts submitted to the Biomedical Sessions will be considered for Display Poster Presentation. 

Social Nursing and Allied Health (SNAH) Abstracts

Deadline: Midnight, Monday, 9th January 2023

SNAH abstract submissions will remain open until Monday 9th January.

Any questions?
Please contact Sinead on: sinead@sineadcassidy.com

Contact Us

13 + 15 =

Contact Us
Irish Association for Cancer Research
9A Coolkill, Sandyford, Dublin 18

T: +353 (0)1 295 8859
E: info@iacr.ie

Irish Association for Cancer Research (IACR) is a registered charity on the Register of Charitable Organisations.

Registered Charity Number (RCN): 20030117

Design by patterns.ie
© 2022